Xeris Pharmaceuticals Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Browse to the end of this webpage for potential risks for Xeris Pharmaceuticals Inc based on sector, location and marketcap. If you are employed by Xeris Pharmaceuticals Inc and you would like to licence your ESG aseessment, please get in touch. This webpage is a free Environmental, Social and Governance assessment covering Xeris Pharmaceuticals Inc.

Xeris Pharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 6.3; made up of an environmental score of 6.0, social score of 4.8 and governance score of 8.0.

green chameleon

1/10 free views/searches used

You're viewing a Free Open ESG Rating.
To access the most comprehensive ESG data experience, Sign up to SEVVA Platform.

SDG Transparency Score for Xeris Pharmaceuticals Inc 
Low
0 - 3

6.3

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2022-07-01
What drives the score for Xeris Pharmaceuticals Inc 
6.0

Environmental

4.8

Social

8.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.8
High
2Eli Lilly and Co
9.5
High
576XSpray Pharma AB (publ)
6.4
High
576Yabao Pharmaceutical Group Co Ltd
6.4
High
595Xeris Pharmaceuticals Inc
6.3
High
595Denis Chem Lab Ltd
6.3
High
595Gritstone bio Inc
6.3
High
.........
2690Zyden Gentec Ltd
0.0
Low
2690Zyla Life Sciences
0.0
Low
.........
View the full peer group of 3274 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Xeris Pharmaceuticals Inc reference operational or capital allocation in relation to climate change?No
No answer found for the question
Does the Board describe its role in the oversight of climate-related risks and opportunities?Yes
company-nameAnnualfiling2021-03-09
Progress reports detailing the results of the clinical trials, among other information, must be submitted at least annual y to the FDA, and written IND safetyreports must be submitted to the FDA and the investigators for serious and unexpected adverse events, findings from other studies that suggest asignificant risk to humans exposed to the product, findings from animal or in vitro testing that suggest a significant risk to human subjects, and anyclinical y important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. Phase 1, Phase 2and Phase 3 clinical trials may not be completed successful y within any specified period, if at al . The FDA or the clinical trial sponsor may suspend orterminate a clinical trial at any time on various grounds, including a finding that the research subjects or patients are being exposed to an unacceptablehealth risk. Similarly, an IRB can suspend or terminate approval of a clinical t...
Sign Up to view this source

Is Capital Expenditure linked to emissions reduction?

Only SubscribersSubscription required

Has Xeris Pharmaceuticals Inc submitted or committed to submit to a shareholder vote (say-on-climate) its climate strategy?

Only SubscribersSubscription required
Does Xeris Pharmaceuticals Inc disclose current and historical air emissions?

Does Xeris Pharmaceuticals Inc disclose current and / or historical ozone-depleting emissions?

LockedSign up for free to unlock
Does Xeris Pharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Does Xeris Pharmaceuticals Inc disclose current and / or historical scope 2 emissions?

Does Xeris Pharmaceuticals Inc disclose current and / or historical scope 3 emissions?

Only SubscribersSubscription required

Does Xeris Pharmaceuticals Inc disclose current and / or historical emissions broken down by scope?

Only SubscribersSubscription required
Does Xeris Pharmaceuticals Inc disclose GHG and Air Emissions intensity?

Does Xeris Pharmaceuticals Inc disclose GHG Targets?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose data for NOx, SOx and VOCs emissions?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose its Scope Emissions targets?

Only SubscribersSubscription required
Does Xeris Pharmaceuticals Inc disclose current and historical energy intensity?

Does Xeris Pharmaceuticals Inc disclose its current and / or historical energy use?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose energy use targets?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Does Xeris Pharmaceuticals Inc disclose its biodiversity policy?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose its forestry policy?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose its internal carbon price?

Only SubscribersSubscription required

Does Xeris Pharmaceuticals Inc disclose long-term targets (>5 years) for reducing its GHG emissions?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose Scope 3 emissions from use of sold products?

Only SubscribersSubscription required

Does Xeris Pharmaceuticals Inc disclose current and historical material use?

LockedSign up for free to unlock
Are Operating Expesnses linked to emissions reduction?
Does Xeris Pharmaceuticals Inc disclose climate scenario or pathway analysis?
Does Xeris Pharmaceuticals Inc reflect climate-related risks in its financial statements?

Does Xeris Pharmaceuticals Inc disclose the number and percentage of companies screened by environmental and social criteria?

Only SubscribersSubscription required

Are emissions metrics verified by CDP?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required
Does Xeris Pharmaceuticals Inc report according to TCFD requirements?

Does Xeris Pharmaceuticals Inc disclose current and historical waste generation?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose current and / or historical waste management?

Only SubscribersSubscription required

Does Xeris Pharmaceuticals Inc disclose waste targets?

Only SubscribersSubscription required

Has Xeris Pharmaceuticals Inc published clear targets on waste management?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose current and / or historical water consumption?

Only SubscribersSubscription required
Does Xeris Pharmaceuticals Inc disclose its waste policy?
Does Xeris Pharmaceuticals Inc disclose water use targets?
Does Xeris Pharmaceuticals Inc condunt supply chain audits?

Does Xeris Pharmaceuticals Inc engage third parties to conduct supply chain audit?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose board meeting attendance?

LockedSign up for free to unlock

Are there worker representatives on the board?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose long term financial targets?

Only SubscribersSubscription required

Does Xeris Pharmaceuticals Inc report NPS (customer loyalty, customer churn or satisfaction surveys) ?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc report customer churn rates?

Only SubscribersSubscription required

Does Xeris Pharmaceuticals Inc have a policy relating to cyber security?

LockedSign up for free to unlock
Does Xeris Pharmaceuticals Inc disclose cybersecurity risks?

Does Xeris Pharmaceuticals Inc adhere to ISO 27001 / ISO 27002 standards or the NIST cybersecurity framework?

Only SubscribersSubscription required

Does Xeris Pharmaceuticals Inc conduct cybersecurity training?

Only SubscribersSubscription required
Does Xeris Pharmaceuticals Inc disclose the individual responsible for D&I?
Does Xeris Pharmaceuticals Inc conduct 360 degree staff reviews?

Does Xeris Pharmaceuticals Inc have engagement surveys, a culture survey, a pulse survey?

LockedSign up for free to unlock
Does Xeris Pharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

Does Xeris Pharmaceuticals Inc disclose the vesting percentage required for performance threshold in the LTIP?

Only SubscribersSubscription required
Has Xeris Pharmaceuticals Inc issued a profit warning in the past 24 months?
Does Xeris Pharmaceuticals Inc report the average age of the workforce?

Does Xeris Pharmaceuticals Inc report internal employee trust metrics such as ENPS?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc permit its workforce to engage in collective bargaining?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose average employee tenure?

Only SubscribersSubscription required

Does Xeris Pharmaceuticals Inc refer to human capital or people risk in its risk disclosures?

Only SubscribersSubscription required

Does Xeris Pharmaceuticals Inc promote decent work conditions in relation to its supply chain?

LockedSign up for free to unlock
Does Xeris Pharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?

Does Xeris Pharmaceuticals Inc report the number of strikes or work related stoppages?

LockedSign up for free to unlock
Does Xeris Pharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?

Does Xeris Pharmaceuticals Inc have a chief innovation officer?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose the ratio of CEO total compensation relative to average employee compensation ?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose its gender pay gap?

Only SubscribersSubscription required
Does Xeris Pharmaceuticals Inc disclose its ethnicity pay gap?
Does Xeris Pharmaceuticals Inc disclose the number of employees in R&D functions?

Does Xeris Pharmaceuticals Inc engage in animal testing?

Only SubscribersSubscription required
Does Xeris Pharmaceuticals Inc engage in stem cell research?

Does Xeris Pharmaceuticals Inc have a commitment to a living wage?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose the vesting schedule of its equity compensation plan?

LockedSign up for free to unlock
Is executive remuneration linked to climate performance?
Does Xeris Pharmaceuticals Inc offer flexible work?

Does Xeris Pharmaceuticals Inc disclose employee diversity metrics?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose employee gender diversity metrics?

LockedSign up for free to unlock
Does Xeris Pharmaceuticals Inc disclose the pay ratio of women to men?
Does Xeris Pharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

Does Xeris Pharmaceuticals Inc disclose information on fatalities and accidents in the workplace

Only SubscribersSubscription required
Does Xeris Pharmaceuticals Inc report instances of occupational ill health, injury and fatality?

Does Xeris Pharmaceuticals Inc disclose reportable workplace incidents?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose the number of employees, new hires and turnover metrics?

Only SubscribersSubscription required
Does Xeris Pharmaceuticals Inc disclose parental leave metrics?

Does Xeris Pharmaceuticals Inc disclose employee training metrics?

LockedSign up for free to unlock
Does Xeris Pharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Xeris Pharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

Does Xeris Pharmaceuticals Inc disclose the number of customer privacy complaints?

Only SubscribersSubscription required
Does Xeris Pharmaceuticals Inc disclose incidents of discrimination?

Does Xeris Pharmaceuticals Inc disclose incidents relating human rights, child labour and forced labour?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose incidents of corruption?

Only SubscribersSubscription required

Does Xeris Pharmaceuticals Inc disclose the number of incidents involving the rights of indigenous peoples?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose incidents of non-compliance in relation to product and service information/labelling or marketing communications?

Only SubscribersSubscription required
Did Xeris Pharmaceuticals Inc have a product recall in the last two years?
Does Xeris Pharmaceuticals Inc support suppliers with sustainability related research and development?
Does Xeris Pharmaceuticals Inc have careers partnerships with academic institutions?
Is Xeris Pharmaceuticals Inc involved in embryonic stem cell research?

Does Xeris Pharmaceuticals Inc avoid gender bias in its hiring?

LockedSign up for free to unlock

Does Xeris Pharmaceuticals Inc disclose the number of hours and/or employees/security personnel trained on human rights policies or procedures?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Xeris Pharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.

Do you want to create your own ESG Scorecard that you can share with your team members?

Sign up for free
ESG Scorecard with Trendline
green chameleon

1/10 free views/searches used

You're viewing a Free Open ESG Rating.
To access the most comprehensive ESG data experience, Sign up to SEVVA Platform.

Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, hypokalemic, and related variants of primary periodic paralysis; and Recorlev, a cortisol synthesis inhibitor proved for the treatment of endogenous hypercortisolemia in adult patients with Cushing's syndrome. It also has a pipeline of development programs to extend the marketed products into new indications and uses and bring new products using its proprietary formulation technology platforms, XeriSol and XeriJect. The company was incorporated in 2005 and is headquartered in Chicago, Illinois.